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Objectives: To assess patient satisfaction and quality of life after urethroplasty us-
ing two different self-reported outcome measures and to compare it with objective 
clinical data.
Materials and Methods: We prospectively collected data from 35 consecutive patients 
who underwent urethroplasty from January 2013 to September 2014. Patient demo-
graphics, International Prostate Symptom Score (IPSS), quality of life score, urethral 
stricture surgery patient-reported outcome measure (USS-PROM), maximum flow rate 
(Qmax) and post-void residual urine were collected before, two and eight months af-
ter surgery. Failure occurred when any postoperative instrumentation was performed. 
General estimation equation was used to compare the results and linear regression 
analysis to correlate both questionnaires with objective data.
Results: Mean age was 61 years. Urethroplasties were equally divided between anas-
tomotic and buccal mucosa grafts and 19 patients (59.3%) had a previous urethral 
procedure. Overall success rate was 87.5%. IPSS improved from a mean 19 at baseline 
to 5.32 at 8 months (p <0.001). The mean USS-PROM score also improved from 13.21 
preoperatively to 3.36 after surgery (p <0.001) and 84.3% of patients were satisfied or 
very satisfied with surgical results. Mean Qmax increased from 4.64mL/s to 11mL/s 
(p <0.001). Strong negative correlation was found respectively between flow rate and 
USS-PROM (r=-0.531, p <0.001) and with IPSS (r=-0.512, p <0.001).
Conclusions: Significant improvements in urinary symptoms and in quality of life are 
expected after urethroplasty and they are correlated with objective measures.
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INTRODUCTION
Urethral strictures are a high complexity 
disease that impacts on quality of life (QoL) with 
an increasing reported incidence in elderly popu-
lation (1). The aim of any intervention is to restore 
patient’s normal pattern of voiding while maintai-
ning a good QoL (2). Urethroplasty is considered the 
gold standard for the management of urethral stric-
ture disease with excellent and durable successful 
reported rates (3, 4). It has already been shown that 
urethroplasty is the most cost-effectiveness strate-
gy compared to minimally invasive procedures in 
the treatment of urethral stricture disease (5, 6).
The definition of what constitutes an ure-
throplasty success varies widely in the literature 
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as well as the methods and frequency used to 
follow-up these patients. This lack of standardiza-
tion makes comparisons between different studies 
difficult (7). Strategies of surveillance can range 
from subjective symptoms questionnaires to more 
invasive testing such cystoscopy and cystoure-
thrography, that impact in the costs and the risks 
involved in this process. Despite reports that voi-
ding symptoms have a good accuracy in predic-
ting stricture recurrence, most outcome measures 
are clinician-driven indicators of technical success 
(8). Little has been published using patient-percei-
ved symptoms and QoL outcomes after urethral 
reconstruction, although the recent development 
of a urethral stricture surgery patient - reported 
outcome measure (USS-PROM) is gaining consi-
derable importance in the evaluation of patients’ 
perception of surgical success (9-11). The purpose 
of the present study was to prospectively analyze 
the pre- and post-operative patient-reported ou-
tcomes measures describing patient’s satisfaction 
and QoL after open urethral reconstruction and to 
compare these results with objective data.
MATERIALS AND METHODS
 We prospectively collected data from a 
cohort of consecutive patients older than 18 ye-
ars old, Portuguese speakers who underwent ure-
throplasty from January 2013 to September 2014. 
The study was approved by the institutional re-
view board of our hospital. Patients were excluded 
if they had not undergone formal reconstruction 
(i.e. perineal urethrostomy). Patients with previous 
open irreversible reconstruction, with evident 
cognitive impairment, or who refused to partici-
pate were also excluded. Patients lost to follow-up 
were excluded from analysis.
 Preoperative evaluation included history 
taking for demographic characteristics. Stricture 
etiology, location and extension of the stenosis 
and previous treatments were collected. Retro-
grade and voiding cystourethrography were done 
preoperatively in all subjects to assess stricture 
length and site. If the patient had a suprapubic 
catheter for urinary diversion an anterograde cys-
tourethrography was performed concomitantly to 
verify the urethral defect. The International Pros-
tate Symptom Score (IPSS), QoL score of the IPSS, 
uroflowmetry, post-void residual urine (PVR) and 
the USS-PROM were collected preoperatively, 2 
and 8 months after urethroplasty at the follow-
-up visits. The USS-PROM was developed in 2011 
(11) as the first questionnaire specifically designed 
for patients with urethral stricture disease. This 
instrument is comprised of a LUTS domain and 
a health-related quality of life domain. The LUTS 
domain is composed by a six-item LUTS bother 
questions that generates a total score that varies 
from 0 (asymptomatic) to 24 (most symptomatic); 
by a separated LUTS-specific QoL question; and 
by the Peeling’s voiding picture, an illustration 
of a man voiding scored between 1 (best) and 4 
(worst). The postoperative USS-PROM is supple-
mented with a treatment satisfaction question. 
The patients were invited to complete the LUTS 
domain and the overall satisfaction question.
 All urethroplasties were performed by a 
single surgeon, and the surgical technique was at 
surgeon’s discretion. Urethral catheter was usually 
removed three weeks after surgery. Cystourethro-
graphy was done postoperatively only in patients 
who complained of urinary symptoms and was 
used to assess urethral patency and to direct fur-
ther treatment if necessary. The surgery was con-
sidered a failure when any postoperative instru-
mentation or reoperation was performed.
 The follow-up scores of IPSS, QoL, USS-
-PROM, Qmax and PVR were compared with pre-
operative scores and among them. The results of 
the IPSS and USS-PROM were also correlated with 
Qmax using linear regression analysis. To show an 
improvement of 10 points in the IPSS and 7mL/s 
in Qmax with a study power of 80% and p value 
<0.05, a sample size of 18 patients was estimated. 
General estimation equation was used to assess 
statistical significance between the baseline and 
postoperative time points. All statistical analysis 
was done using SPSS® 18.0 with 2-sided signifi-
cance considered at p <0.05.
RESULTS
 A total of 35 consecutive patients were 
included, of whom 3 were lost to follow-up and 
excluded from analysis. The mean age was 61 
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years (range 24-82). The average stricture length 
was 4.2cm (range 1-13) and strictures were loca-
ted mainly in the bulbar urethra. The most com-
monly identifiable etiology was trauma in 11 pa-
tients (34.4%). In 16 patients (50%) a suprapubic 
urinary diversion was required due to complete 
urinary retention, thus obviating the preoperative 
assessment of subjective and objective data. A to-
tal of 18 (56.2%) substitution dorsal onlay repairs 
using buccal mucosa and 14 (43.7%) excision and 
primary anastomosis urethroplasties were done. 
Nineteen patients (59.3%) had undergone a pre-
vious urethral procedure. The overall success rate 
in the 8-month follow-up period was 87.5%, with 
all 4 urethroplasty failures presenting before the 
2-month schedule visit with progressive worse-
ning of voiding symptoms. Baseline data are sum-
marized in Table-1.
 Mean preoperative IPSS score was 19 
and significantly decreased to 4.96 and 5.32 at 
the 2 and 8-months visit respectively (p <0.001). 
This small raise in IPSS in the follow-up period 
was not statistically significant. Patients also 
showed a significant improvement in QoL sco-
res of the IPSS from 4.71 to 1.17 in the 2 and 
8-month consultation (p <0.001). The mean im-
provements for IPSS and QoL score in individu-
al patients at 8-months were respectively 13.64 
(95% CI 18.14–9.13, p <0.001) and 3.43 (95% CI 
4.20–2.65, p <0.001, Table-2).
 The mean six-item LUTS score of the USS-
-PROM questionnaire was 13.21 at baseline, 2.46 
two months after urethroplasty, and 3.36 eight 
months after urethroplasty (p <0.001). This worse-
ning in LUTS score between the 2 and 8 month’s 
evaluation was not significant (p=0.193). The 
LUTS score showed a mean decrease of 9.21 points 
(95% CI 12.70–5.71, p <0.001, Table-2). The mean 
Peeling’s voiding picture score improved from 3.64 
at baseline to 1.79 two months after urethroplasty 
(p <0.001). The 8-month score was 2.04 and was 
a trend towards worsening between the 2 and 8 
month’s score, but without significance (p=0.064). 
The mean LUTS-specific QoL question was 3.21 at 
the preoperative evaluation and dropped to 1.36 
at the 8-month follow-up (p <0.001). Overall 27 of 
32 men (84.3%) of the patients were “satisfied” or 
“very satisfied” with the results of their urethro-
Table 1 – Baseline characteristics.
Mean age, year (range) 61 (24 – 82)
Mean stricture length, cm (range) 4.2 (1 – 13)
n (%)
Stricture site
Penile 8 (25)
Bulbar 14 (43.7)
Bulbo-penile 4 (12.5)
Membranous 4 (12.5)
Panurethral 2 (6.2)
Etiology
Trauma 11 (34.4)
Iatrogenic 7 (21.8)
Infectious 4 (12.5)
Idiopathic 10 (31.2)
Suprapubic catheter 16 (50)
Procedure performed
Buccal mucosa graft 18 (56.6)
Anastomotic 14 (43.7)
Previous Intervention 19 (59.3)
DVIU 6 (18.7)
Dilatation 10 (31.2)
Urethroplasty 5 (15.6)
DvIU = Direct vision internal urethrotomy
plasty at 8 months. From the 5 patients that were 
unsatisfied, 4 had recurrence of the stricture with 
worsening of their symptoms, requiring surgical 
reintervention.
The mean Qmax at baseline was 4.64mL/s 
and significantly increased to 11.11mL/s and 
11mL/s, respectively at two and eight months (p 
<0.001). The mean improvement in Qmax from 
preoperative assessment to the 8-month evaluation 
was 7.02 (95% CI 3.22–10.77, p <0.001, Table-2). 
Mean PVR decreased from 41.04mL preoperatively 
to 5.07mL at the final visit of the study (p=0.017). 
The preoperative and postoperative USS-PROM 
and IPSS scores were compared with Qmax using 
linear regression analysis and a strong negative 
correlation was found for both (r=-0.531, p <0.001; 
r=-0.512, p=0.001, respectively; Figure-1). When 
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patients were divided and analyzed by procedure 
type or by the presence of preoperative suprapubic 
urinary catheter, no signifi cant differences were 
seen for IPSS, QoL, Qmax and USS-PROM in the 
post-urethroplasty assessment.
DISCUSSION
 This study presents patient-reported ou-
tcomes measures after urethroplasty using two di-
fferent questionnaires for this purpose with each 
patient as his own control. We demonstrated con-
tinuous relief in IPSS, QoL and USS-PROM scores 
8-months after urethroplasty with 84.3% of pa-
tients being satisfi ed or very satisfi ed with sur-
gical results. For many surgeries the motivating 
factor is QoL, thus it is critical to know how sa-
tisfi ed patients are after undergoing urethroplasty 
both for counseling and following these patients 
up. Kessler et al. was among the fi rst to highlight 
that subjective measures should be included in the 
assessment of urethroplasty outcomes (9). They 
noted that of 30 patients who were considered a 
failure by the surgeon’s perspective, 24 were sub-
jectively satisfi ed or very satisfi ed with the surgi-
cal outcome, showing that patients may consider 
the outcomes differently than surgeons.
In addition to symptoms questionnaires we 
used urofl owmetry and PVR to evaluate surgical 
outcomes, and also demonstrated signifi cant im-
provements after urethral reconstruction. Many 
investigators have used urofl owmetry to determi-
ne the success of urethroplasty, but usually do not 
correlate it with subjective fi ndings (8, 12, 13). In 
our study, the mean Qmax improved from 4.64mL/s 
Table 2 – Baseline to 8-month postoperative differences.
Baseline Mean
(95% CI)
8-mo Mean
(95% CI)
P Value Mean Difference
(95% CI)
P Value
USS-PROM 13.21
(10.19 – 16.24)
3.36
(2.22 – 4.49)
<0.001 -9.21
(-12.70 to -5.71)
<0.001
IPSS 19
(14.45 – 23.55)
5.32
(3.87 – 6.78)
<0.001 -13.64
(-18.14 to -9.13)
<0.001
QoL 4.71
(4.05 – 5.37)
1.17
(0.71 – 1.85)
<0.001 -3.42
(-4.20 to -2.65)
<0.001
Qmax (mL/s) 4.64
(3.59 – 5.70)
11
(8.65 – 13.35)
<0.001 7.02
(3.22 to 10.77)
<0.001
PVR (mL) 41.04
(12.33 – 69.69)
5.07
(1.55 – 8.60)
0.017 -35.92
(-63.90 to -7.95)
<0.001
CI = Confi dential Interval; USS-PROM = Urethral stricture surgery patient-reported outcome measure; IPSS = International Prostate Symptom Score; QoL = quality of life; 
Qmax = maximun fl ow rate; PvR = postvoid residual urine
Figure 1 – Correlations between USS-PROM and IPSS scores 
with Qmax showing strong negative correlation.
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preoperatively to 11mL/s 8 months after surgery. 
These improvements in Qmax were more modest 
when compared with those reported in other series 
(12, 14). Maybe this occurred because our patients 
were older (mean age of 61 years), a group where a 
large number of men have a component of benign 
prostatic hyperplasia or have a long-standing ure-
thral obstruction with detrusor dysfunction. Accor-
dingly, DeLong et al. found a median improvement 
in Qmax of 12mL/s after surgery, but when split-
ting the cohort by age, patients with less than 45 
years experienced an improvement of 16mL/s vs. 
8mL/s achieved in those older than 45 years (15). 
Both studies highlight that the differences betwe-
en the preoperative and postoperative data using 
the patient as his own control is, perhaps, more 
important than setting a Qmax cutoff at which all 
men should be evaluated for stricture recurrence. 
Differently, our self-reported outcomes represen-
ted by the USS-PROM, IPSS and QoL scores were 
not diminished by the lesser improvement in Qmax 
and the results were in accordance with the few 
studies that analyzed these questionnaires pre- and 
postoperatively (10, 14-16).
Monitoring patient symptoms should be 
a crucial part in any surveillance protocol for 
stricture recurrence. It is easy, readily available, 
cheap and with no adverse events reported. IPSS, 
although developed to assess treatments for be-
nign prostatic hyperplasia, is the most frequently 
used questionnaire in the evaluation of urethro-
plasty outcomes (7). It was first used by Morey et 
al. who demonstrated significant improvements in 
IPSS after successful reconstruction and a strong 
negative relationship between the IPSS and Qmax 
(16), a finding also demonstrated in a subsequent 
study (13). Voelzke et al. in a systematic review 
of the literature examining the use of patient-re-
ported outcome measures after anterior urethro-
plasties found only 4 articles that used a LUTS 
instrument (2). The development of a specific 
instrument to assess urethroplasty outcomes was 
necessary, a step made by Jackson et al., who in 
2011 developed and validated a USS-PROM as an 
attempt to standardize patient-centered evalua-
tions of interventions for urethral strictures (11). 
In 2013 the same group presented the first pa-
per that prospectively evaluated the USS-PROM 
reporting continuous relief of patient’s symp-
toms and QoL in the 2-year follow-up period, 
setting a reference point which other groups can 
compare their performances with (10). The USS-
-PROM was also recently validated to Italian 
and German (17, 18).
 Our cohort was only the second to report 
prospectively the results of the USS-PROM after 
urethroplasty and shows comparable outcomes. 
Overall 84% of our patients were satisfied or 
very satisfied with the results of urethroplasty at 
8 months, compared to the 87% satisfaction rate 
reported by Jackson et al. (11). We found that the 
self reported six-item LUTS score significantly 
decrease postoperatively from 13.21 to 3.36 at 8 
months, a better result than the 5.4 reported by 
the same group at a 2-year follow-up visit, but 
similar to the 3.4 score described by them at the 
6-month survey. Moreover, we observed a strong 
negative correlation between the LUTS score and 
Qmax (r=-0.531, p <0.001), resembling the cor-
relations described for Qmax and IPSS in other 
series (13, 16). The changes in Peeling’s voiding 
picture and in the LUTS-specific QoL question in 
our study also did not differ from that reported 
by Jackson.
 To date the best strategy to evaluate stric-
ture recurrence is not clear. Instead of this there are 
many different protocols varying from invasive 
testing such cystoscopy and voiding cystourethro-
graphy to non-invasive like questionnaire symp-
toms and uroflowmetry employed in surveillance 
regimens after urethroplasty. This is demonstrated 
by Meeks et al. who performed a meta-analysis 
and found an average of 3.15 different diagnos-
tic tests for this purpose after surgery (19). This 
lack of standardization makes comparisons across 
different studies difficult as well as the ability to 
perform meta-analysis difficult, highlighting that 
follow-up protocols remains extremely variable.
 Our study has some limitations, including 
that half of our population had a suprapubic tube, 
and this might have overestimated the results. We 
tried to minimize this effect using the General Es-
timation Equation in the statistical analysis. We 
also recognize that Qmax and especially PVR may 
not be enough to determine the anatomical suc-
cess of the surgical repair. On the other hand, one 
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of the objectives of our study was to correlate this 
non-invasive methods with subjective measures 
of success. For this purpose, further studies with 
more patients and longer follow-up are necessary. 
Additionally, the USS-PROM is not still formally 
validated to Portuguese.
 In our practice, we use a multi-tier ap-
proach to screen patients after urethroplasty. We 
start with symptoms questionnaires, uroflowme-
try and PVR comparing the results with the data 
collected preoperatively. If symptoms of voiding 
difficult or changes in uroflowmetry are present, 
we than proceed to more invasive evaluation. We 
found this strategy helpful in identifying recur-
rences while keeping patients comfort, favoring a 
less-expensive regimen. Furthermore, there is no 
evidence in the literature that early treatment of 
an asymptomatic recurrence is beneficial. Another 
issue of growing importance is the cost involved 
in the follow-up strategy in an era of increasing 
health care costs. Belsante et al. reported that a 
symptom-based, risk-stratified follow-up proto-
col would be far most cost-effective than close 
follow-up in all patients after urethroplasty, mis-
sing less than 1% of an asymptomatic recurrence 
(20). It has also been demonstrated that the first 
year charges of anterior urethroplasty surveillance 
can range from $205 to $1784 depending on the 
strategy adopted (21). It is our belief that urethral 
reconstruction is a quality of life surgery, and as 
long as the patient is satisfied with his symptoms, 
perform routinely invasive tests is, sometimes, 
overly aggressive, exposing patients to unnecessa-
ry risks and will usually not change management 
until patient feels symptomatic. The adoption of 
a disease-specific instrument like the USS-PROM 
questionnaire is of great value since it could help 
patients and physicians predict their outcomes 
and satisfaction.
CONCLUSIONS
 
We have demonstrated that urethroplasty 
is a well-tolerated and worthwhile procedure by 
patient’s point of view. We have shown with both 
patient-reported outcomes and objective measures 
a significant improvement in symptoms, QoL sco-
res and Qmax after urethral reconstruction using 
patients as their own control. Harmonization of 
surveillance protocols is clearly necessary as a 
method to more effectively compare the results 
between different reconstructive procedures and 
institutions. The use of a tool specifically desig-
ned to access urethral stricture disease is a great 
advance in this field and should be encouraged as 
an attempt to minimize costs and to incorpora-
te the patients perspective in this process. Further 
studies are necessary to establish the optimal sur-
veillance protocol for stricture recurrence and the 
place of PROMs in this setting.
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